Clinical trial
Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation
NCT03867851 · TikoMed AB, Industry · Terminated
Key facts
| NCT number | NCT03867851 |
|---|---|
| Title | Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation |
| Official title | Open, Randomized, Active Comparator-controlled, Multi-Center Study to Evaluate Safety and Efficacy of IBsolvMIR® in Islet Transplantation |
| Lead sponsor | TikoMed AB, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | IBsolvMIR, Heparin |
| Enrollment | 7 |
| Start date | Feb 8, 2021 |
| Primary completion | May 13, 2024 |
| Completion | May 13, 2024 |
| First posted | Mar 8, 2019 |
| Last update posted | May 16, 2024 |
| Countries | Netherlands, Norway, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: